Travere Therapeutics (TVTX) shares soared 26.2% in the last trading session to close at $27.31. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Travere Therapeutics stock tanked yesterday as the company reported its kidney disease drug FILSPARI had failed to meet its key endpoint in a confirmatory study. TVTX shares fell to ~$8 - down 40% for ...

Travere Therapeutics’ kidney disease strategy has hit a snag. A pivotal phase 3 trial of sparsentan missed its primary endpoint, but the biotech is undeterred, outlining plans to talk to the FDA about ...

Travere Therapeutics (TVTX) announced that the Company will present 11 abstracts, including a late-breaking poster, at the upcoming American ...

Investors might want to bet on Travere Therapeutics (TVTX), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

Travere Therapeutics (NASDAQ:TVTX) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ...

Travere Therapeutics, Inc. (NASDAQ:TVTX) - a $1.4bn market cap (at the time of writing) commercial stage, San Diego-headquartered biotech - ought to be on investors' watchlists ahead of a pivotal ...

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on October 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of ...

4 analysts have expressed a variety of opinions on Travere Therapeutics (NASDAQ:TVTX) over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent ...

Travere Therapeutics, Inc. (NASDAQ:TVTX) shares are trading higher on Wednesday after the company announced that it was informed by the FDA that an advisory committee is no longer needed following ...

Travere Therapeutics Inc TVTX has agreed to sell its bile acid product portfolio that, which includes Cholbam (cholic acid) and Chenodal (chenodiol), two medications, to Mirum Pharmaceuticals Inc MIRM ...